APG1252
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APG1252, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML [Phase 1, Phase 2]